PTX treatment significantly increased inflammasome activation, as indicated by significantly increased NLRP3, ASC, NOD2 and AIM2 (p < 0.0001) expression in MDA-MB-231 tumor cells compared to control cells. The gene discussed is NLRP3; the disease is neoplasm.